Update: vildagliptin for the treatment of Type 2 diabetes

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.1, 2008-01, pp. : 105-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vildagliptin in the treatment of type 2 diabetes mellitus

By Stamataros George Schneider Stephen H

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. : 1967-1973

Informa Healthcare

Access to resources Recommend Favorite

Vildagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of type 2 diabetes

By Stein Stephanie A Lamos Elizabeth M Davis Stephen N

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 4, 2014-04 ,pp. : 599-608

Informa Healthcare

Access to resources Recommend Favorite

Vildagliptin, a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metformin

By Forst Thomas Bramlage Peter

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 9, 2014-06 ,pp. : 1299-1313

Informa Healthcare

Access to resources Recommend Favorite

Vildagliptin: A Review of its Use in Type 2 Diabetes Mellitus

By Keating Gillian M.

Drugs, Vol. 70, Iss. 16, 2010-11 ,pp. : 2089-2112

Adis International

Access to resources Recommend Favorite

Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus

By Guarino Elisa Nigi Laura Patti Aurora Fondelli Cecilia Dotta Francesco

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1377-1384

Informa Healthcare

Access to resources Recommend Favorite